Technology
e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Device holds promise of a cure for atrial fibrillation

St. Petersburg Times, January 14, 2011
The Food and Drug Administration has approved Medtronic's Arctic Front device a for atrial fibrillation patients who don't respond to drug therapy. This week at St. Joseph's Hospital in Tampa, a patient became one of the first people in the nation to have the procedure outside a clinical trial. Mayo Clinic in Rochester, MN, was the site of the first, just last week. Arctic Front uses a tiny balloon that is threaded up to the heart in a catheter inserted through a vein in the leg. Once in the pulmonary vein, the balloon is inflated and cooled to minus 90 degrees Celsius ? or minus 130 degrees Fahrenheit. All cells that come in contact with the balloon are killed, wiping out cells responsible for the irregular heart rhythm. Other A-fib treatment devices use heat or cold to damage the area in certain spots, but they can't cover all the area that the balloon covers.

Comments are moderated. Please be patient.